Results
1 -
9 of
9K. Ravikumar and B. Sridhar.
Granisetron, an antiemetic drug, and its cobalt complex, Acta Cryst. (2010). C66, m35-m39Â Â Â Â Del Cadia Marta, De Rienzo Francesca, Weston David A., Thompson Andrew J., Menziani Maria Cristina, Lummis Sarah C.R..
Exploring a potential palonosetron allosteric binding site in the 5-HT3 receptor, Bioorganic & Medicinal Chemistry, 2013 Getting it right the first time: recent progress in optimizing antiemetic usage, Supportive Care in Cancer Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial, Supportive Care in Cancer Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy, BMC Cancer First-Generation 5-HT3 Receptor Antagonists, Management of Chemotherapy-Induced Nausea and Vomiting Controlled-release mepivacaine, bupivacaine: similar for post-surgical pain relief, Inpharma Weekly Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances [Online], Thieme: Stuttgart, (2003)..
Granisetron, Pharmaceutical Substances